ReviewSensors (Basel, Switzerland)2026
Neuromorphic Technologies for Neuroengineering: From Adaptive Stimulation to SNN-Based Inference and Deployable Biointerfaces.
Review in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Neuromorphic technologies are attracting increasing interest in neuroengineering, as they provide an event-driven, spike-based computational framework that is well suited to temporally structured, sparse, and resource-constrained biological systems. Compared with conventional computing pipelines, neuromorphic approaches enable tighter integration of sensing, encoding, inference, feedback, and actuation under low-power and low-latency conditions. These features make them particularly relevant for wearable, implantable, and other edge-native neuroengineering applications. This review examines neuromorphic neuroengineering from four closely related perspectives: neuromorphic neurostimulation and adaptive actuation; tactile and sensory biointerfaces; spiking neural network (SNN)-based biosignal processing and state decoding; and wearable or implantable neuromorphic platforms. Across these domains, we highlight how neuromorphic systems may facilitate edge-native, closed-loop architectures that operate closer to the body and respond selectively to meaningful state changes. Neurorehabilitation is further discussed as an important translational context, as it involves long-term use, multimodal sensing, adaptive intervention, and substantial real-world deployment constraints. At present, however, the evidence base remains fragmented and is still largely dominated by device demonstrations and proof-of-concept studies rather than robust translational validation. Overall, neuromorphic approaches offer a promising systems-level pathway toward neuroengineering platforms that are not only computationally efficient but also adaptive, deployable, and responsive in real-world settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.